Skip to main content
05_Bernardo_Franklin
© Photo: Bruna Guerra Photography

News categories: Honors & Funding

ERC Proof of Concept Grants for UNBIAS

European Research Council is supporting the journey from basic research to application

Prof. Bernardo Franklin from the Institute of Innate Immunity at the University Hospital Bonn has been awarded a Proof of Concept Grant by the European Research Council (ERC) as part of a program designed to help researchers translate their ideas from previous ERC projects into commercial applications. The project is awarded with a funding of €150,000, provided over a period of around one year.

ImmunoSensation2 member Prof. Dr. Bernardo S. Franklin studies hematopoietic stem cells (HSCs), which develop into different blood cells through processes of cell division and differentiation. “Bouts of inflammation that a person experiences as they get older will damage these stem cells,“ Bernardo S. Franklin says. “Processes like this cause hyperactivation of the innate immune system in the elderly.” This phenomenon, known as “inflammaging,” increases the risk of conditions including cardiovascular disease, diabetes and cancer, he adds.

“Wiping” the immune system’s harmful memories of inflammation


The project that has now secured ERC funding, which is entitled “Nanobodies to prevent hematopoietic stem cell bias and hyper-inflammation” (UNBIAS), aims to return HSCs to their original state in order to “wipe” the immune system’s harmful memories of inflammation. The researchers are using customized “mini-antibodies” known as nanobodies to achieve this. These antibodies, which are very small in relative terms, are taken from the blood of alpacas and can break up the places where inflammation develops.

Back in 2017, Franklin received a much-sought-after Starting Grant from the ERC worth some €1.5 million in funding. The Proof of Concept Grant will now build on this work already done. “Our aim is to validate the use of nanobodies to combat inflammaging and license this technology or its applications for industrial partners,” Franklin says. He believes that the project has the potential to alleviate the effects of inflammation and thus potentially save countless lives and the economic cost of illness.

Contact

Prof. Dr. Bernardo S. Franklin

Institute for Innate Immunity

University Hospital Bonn

Phone +49 228 28751981

Email: franklin@uni-bonn.de

Related news

Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

News categories: Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry
25 Millionen Euro für die Bonner KI-Krebsforschung: (v.l.) Prof. Dr. Bernd Weber, Prof. Dr. Michael Hölzel, Prof. Dr. Jürgen Bajorath und Prof. Dr. Uwe Reuter, beim Auftakt von AI4CancerCure.NRW in der Staatskanzlei Nordrhein-Westfalen.

News categories: Honors & Funding

€25 Million for AI-Powered Cancer Research in Bonn

University Hospital Bonn (UKB), the University of Bonn and the Lamarr Institute for Machine Learning and Artificial Intelligence are using funding from the state of North Rhine-Westphalia to establish a joint research infrastructure. The aim is to use AI to design and optimize potential cancer therapeutics and subsequently test them in the laboratory. Minister-President Hendrik Wüst and Minister of Science Ina Brandes presented the funding commitment today at the State Chancellery of North Rhine-Westphalia.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry

Back to the news overview